One size does not fit all for knee replacements and other medical devices

Undergoing a knee replacement involves sophisticated medical equipment, but innovative prosthetic design may not offer the same benefits for all knee replacement recipients, Yale School of Medicine researchers report in a perspective article in the October 20 issue of New England Journal of Medicine.

Devices like pacemakers, artificial joints, and defibrillators have extended lives and improved the quality of life for countless people. Medical device manufacturing has turned into a multi-billion dollar industry, with the United States spending an estimated $95 billion on these devices last year alone, according to the article, which also noted that oversight of device innovation is under scrutiny for safety issues.

The current expedited approval process for low-risk medical devices is based on claims of similarity to previously approved devices, and as such may encourage development of devices that provide only small improvements at higher cost than their predecessors, note the researchers.

To assess whether the addition of a new medical devices to market would yield a greater benefit than using an older version, first author Lisa G. Suter, M.D., assistant professor of at Yale School of Medicine, and colleagues used a to simulate the consequences of undergoing total for end-stage knee osteoarthritis with both standard and innovative implants. Knee osteoarthritis is a frequent and costly cause of disability in the United States.

The researchers used the Osteoarthritis Policy Model, a validated of natural history and management, to project life expectancy and implant survival associated with using standard and innovative implants for both young and older total knee replacement recipients with and without illness.

Suter and her team found that older patients or those with multiple co-existing conditions may not live long enough to benefit from small, incremental gains in the durability of the implant.

"Patients, physicians, device manufacturers, and policymakers should be aware that innovative medical devices may not offer equal value in all patients," said Suter, who added that mathematical models may improve medical device development, evaluation and monitoring.

More information: N Engl J Med 365;16 NEJM.ORG (Oct. 20, 2011)

Related Stories

No justification for denying obese patients knee replacements

Jul 24, 2008

There is no justification for denying obese patients knee replacement surgery: They benefit almost as much as anyone else from the procedure, concludes a small study published ahead of print in the Annals of the Rheumatic Di ...

HRT increases likelihood of hip and knee replacement

Oct 28, 2008

(PhysOrg.com) -- Having more children and using hormone replacement therapy (HRT) increases the likelihood that women will have joint replacement surgery, a large Oxford University-led study has shown.

Recommended for you

Were clinical trial practices in East Germany questionable?

16 hours ago

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments